Amphotericin B inhalation powder represents the first inhaled anti-fungal therapy under development for immunosuppressed patients. The fast track designation includes patients receiving organ or stem cell transplants, or
Dyax’ proprietary drug discovery technology is used to identify antibody, small protein and peptide compounds for clinical development. For example, Dyax identified its lead product candidate DX-88, and
CoFactor is a biomodulator drug designed to improve the efficacy and safety of the widely used chemotherapeutic agent 5-fluorouracil (5-FU). Adventrx remains on track to initiate the phase
Talotrexin (PT-523), a novel nonpolyglutamatable antifolate drug, is currently being evaluated in a phase I/II multicenter clinical trial in patients with relapsed or refractory acute lymphoblastic leukemia (ALL).
Study 09 is a randomized, double-blind, placebo-controlled study being conducted in Europe. The primary endpoint is the proportion of patients with at least a 50% improvement in the
The SkyePharma-developed version of the drug is designed to have an improved pharmacokinetic profile and is expected to replace the current version and to expand the market opportunity
The technique, known as ultrasound-targeted microbubble destruction (UTMD), delivers insulin genes to the organ via microscopic ‘bubbles.’ Once the bubbles reach their target, they are burst with ultrasound,
The data was presented at the 101st American Urological Association (AUA) annual meeting held in Atlanta, Georgia. In the study, independent investigators from Ulm, Germany, and Boston, Massachusetts,
Novavax' testosterone medicine, which is applied as a lotion, is currently in phase II clinical development. Esprit will receive exclusive rights to market the product in North America.
According to an internal FDA communication first reported in the Wall Street Journal, the FDA has received reports of 12 cases of liver failure, including four deaths, in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.